EGFR and Miyoshi myopathy: The increased activities of EGFR and STAT3 were suppressed by CASIN treatment, suggesting that the dominant effects of CASIN on bortezomib-resistant MM cell proliferation and survival are attributable to its suppression of EGFR/STAT3 signaling pathway.